Apogee Enterprises (APOG) earnings
In the quarter ended August 2026, Apogee Enterprises had revenue of $391M, up 9.2% on a year earlier, and diluted EPS of 1.07.
On October 6, 2026 it reported EPS of 1.17 against an estimate of 0.59 (beat).
Report dates
| Report | Date | Time | EPS estimate | EPS reported |
|---|---|---|---|---|
| Last | Tue Oct 6, 2026 | Before open | 0.59 | 1.17 |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Quarterly results
The last 12 quarters from Apogee Enterprises's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | $391M | +9.2% | 1.07 | -2.7% | 8.6% | 2026-10-06 |
| May 31, 2026 | $343M | -1.1% | 0.54 | — | 5.5% | 2026-06-30 |
| Feb 28, 2026 | $351M | +1.6% | — | — | 7.3% | 2026-04-24 |
| Nov 30, 2025 | $349M | +2.1% | 0.77 | -19.8% | 7.1% | 2026-01-07 |
| Aug 31, 2025 | $358M | +4.6% | 1.10 | -21.4% | 7.5% | 2025-10-09 |
| May 31, 2025 | $347M | +4.6% | -0.13 | -109.2% | 2.0% | 2025-07-02 |
| Feb 28, 2025 | $346M | -4.5% | — | — | 1.8% | 2025-04-24 |
| Nov 30, 2024 | $341M | +0.5% | 0.96 | -22.0% | 8.4% | 2025-01-07 |
| Aug 31, 2024 | $342M | -3.2% | 1.40 | -7.9% | 12.3% | 2024-10-04 |
| May 31, 2024 | $332M | -8.3% | 1.41 | +34.3% | 12.5% | 2024-07-09 |
| Feb 29, 2024 | $362M | +5.2% | — | — | 6.0% | 2024-04-26 |
| Nov 30, 2023 | $340M | -7.6% | 1.23 | +15.0% | 11.1% | 2024-01-03 |
Questions
How did Apogee Enterprises do last quarter?
In the quarter ended August 2026, Apogee Enterprises had revenue of $391M, up 9.2% on a year earlier, and diluted EPS of 1.07.
From Apogee Enterprises's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.